Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.457
L. Torralba, N. Labrador, M. Toledo, C. Jiménez, R. Prieto, A. Rubio, A. Domínguez, P. Moya
{"title":"5PSQ-121 Cytokine release syndrome related to the treatment with teclistamab: a case report","authors":"L. Torralba, N. Labrador, M. Toledo, C. Jiménez, R. Prieto, A. Rubio, A. Domínguez, P. Moya","doi":"10.1136/ejhpharm-2023-eahp.457","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.457","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81936154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.387
V. Vázquez Vela, V. Sánchez-Matamoros Piazza, C. Bermúdez Tamayo, M. L. López Muñoz, C. Cuadros Martínez, MM Silva Castro
Background and ImportanceThe opening of a pharmaceutical care service for onco-haematology patients (OHP) in the midst of the health care crisis caused by the COVID19 pandemic, made it possible to maintain the healthcare activity, avoid the collapse and provide the opportunity to implement Comprehensive Medication Management (CMM).Aim and ObjectivesTo investigate the pharmacotherapeutic experience of OHP in outpatient therapy with CMM services;to know important aspects perceived for the identification of barriers/facilitators that determine the quality of the service and proposals for improvement.Material and MethodsDescriptive observational design with a qualitative approach, using informal and semi-structured in-depth interviews (participant observation and peer review) during January-June 2021. ATLAS.ti software was used for content analysis. Oncohaematology patients in outpatient therapy with any medication-related problem and who received CMM services were interviewed. Those who, due to cognitive limitation, could not be interviewed or who did not have a caregiver/family member available were excluded.Results19 interviews were conducted: 57.89% patients and 42.10% caregivers;57.89% were women. All patients were very satisfied with the care received, the vast majority preferred to be attended by a pharmacist, and valued telepharmacy as an alternative or complementary option. The vision of the pharmacy professional as an expert in medicines improves. They suggest improvement related to location, waiting times and greater accessibility of the pharmacist. After the researchers' reflective process, were identified as barriers: care pressure, limited time/resources, lack of interlevel coordination, and facilitators: prioritisation of interventions, integration of pharmacist in the multidisciplinary team, trust in the pharmacist and the new model of care. Improvement strategies: provision of human/material resources with release of pharmacist's time to provide the CMM, extension of hours, information management with the development of personal learning environment and use of programs for recording/integration of information and interventions.Conclusion and RelevanceDelving into patients‘ experiences can be key to improving the quality of care. In our case, the implementation of the CMM service in OHP has been a challenge and an opportunity in the current context of the COVID-19 pandemic. The pharmacy adapted to the needs and implemented a new model of care with excellent acceptance by users.References and/or AcknowledgementsConflict of InterestNo conflict of interest
{"title":"4CPS-069 Experience of onco-haematology patients in outpatient therapy with comprehensive medication management in the context of a COVID 19 pandemic","authors":"V. Vázquez Vela, V. Sánchez-Matamoros Piazza, C. Bermúdez Tamayo, M. L. López Muñoz, C. Cuadros Martínez, MM Silva Castro","doi":"10.1136/ejhpharm-2023-eahp.387","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.387","url":null,"abstract":"Background and ImportanceThe opening of a pharmaceutical care service for onco-haematology patients (OHP) in the midst of the health care crisis caused by the COVID19 pandemic, made it possible to maintain the healthcare activity, avoid the collapse and provide the opportunity to implement Comprehensive Medication Management (CMM).Aim and ObjectivesTo investigate the pharmacotherapeutic experience of OHP in outpatient therapy with CMM services;to know important aspects perceived for the identification of barriers/facilitators that determine the quality of the service and proposals for improvement.Material and MethodsDescriptive observational design with a qualitative approach, using informal and semi-structured in-depth interviews (participant observation and peer review) during January-June 2021. ATLAS.ti software was used for content analysis. Oncohaematology patients in outpatient therapy with any medication-related problem and who received CMM services were interviewed. Those who, due to cognitive limitation, could not be interviewed or who did not have a caregiver/family member available were excluded.Results19 interviews were conducted: 57.89% patients and 42.10% caregivers;57.89% were women. All patients were very satisfied with the care received, the vast majority preferred to be attended by a pharmacist, and valued telepharmacy as an alternative or complementary option. The vision of the pharmacy professional as an expert in medicines improves. They suggest improvement related to location, waiting times and greater accessibility of the pharmacist. After the researchers' reflective process, were identified as barriers: care pressure, limited time/resources, lack of interlevel coordination, and facilitators: prioritisation of interventions, integration of pharmacist in the multidisciplinary team, trust in the pharmacist and the new model of care. Improvement strategies: provision of human/material resources with release of pharmacist's time to provide the CMM, extension of hours, information management with the development of personal learning environment and use of programs for recording/integration of information and interventions.Conclusion and RelevanceDelving into patients‘ experiences can be key to improving the quality of care. In our case, the implementation of the CMM service in OHP has been a challenge and an opportunity in the current context of the COVID-19 pandemic. The pharmacy adapted to the needs and implemented a new model of care with excellent acceptance by users.References and/or AcknowledgementsConflict of InterestNo conflict of interest","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84050802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.455
G. Calzado Gómez, MA Navarro Dávila, S. Perez Reyes, C. Romero Delgado, S. Otazo Perez, Y. González Pérez, M. Bullejos Molina, G. Nazco Casariego
{"title":"5PSQ-114 Persistence and level of clearance in patients with moderate-to-severe psoriasis treated with guselkumab","authors":"G. Calzado Gómez, MA Navarro Dávila, S. Perez Reyes, C. Romero Delgado, S. Otazo Perez, Y. González Pérez, M. Bullejos Molina, G. Nazco Casariego","doi":"10.1136/ejhpharm-2023-eahp.455","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.455","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78670931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.386
Mdp Briceño Casado, MD Gil-Sierra, C. Cuadros-Martinez, B. de la Calle-Riaguas, R. Gavira-Moreno
{"title":"4CPS-064 Effectiveness of ribociclib and abemaciclib as first line treatment for metastatic breast cancer in post-menopausal women","authors":"Mdp Briceño Casado, MD Gil-Sierra, C. Cuadros-Martinez, B. de la Calle-Riaguas, R. Gavira-Moreno","doi":"10.1136/ejhpharm-2023-eahp.386","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.386","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88124561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.422
J. Llata, D. Anguita, A. Arévalo, P. Lalueza, J. Juárez, J. Serracanta, S. Marquina, J. Baena
{"title":"4CPS-224 Impact of augmented renal clearance on antimicrobial dosing in severely burned patients","authors":"J. Llata, D. Anguita, A. Arévalo, P. Lalueza, J. Juárez, J. Serracanta, S. Marquina, J. Baena","doi":"10.1136/ejhpharm-2023-eahp.422","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.422","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91423593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.470
P. Ciudad Gutiérrez, Á. Villalba Moreno, MT Montserrat García, S. Flores Moreno, L. Rodríguez De Francisco, ER Alfaro Lara
{"title":"6ER-018 Off-label use of ustekinumab in refractory epidermolytic ichthyosis: a case report","authors":"P. Ciudad Gutiérrez, Á. Villalba Moreno, MT Montserrat García, S. Flores Moreno, L. Rodríguez De Francisco, ER Alfaro Lara","doi":"10.1136/ejhpharm-2023-eahp.470","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.470","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78536642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.465
B. Santos Ramos, H. Rodríguez-Ramallo, A. Rodríguez-Pérez, L. Rodríguez Defrancisco, M. Fernández González
{"title":"6ER-006 Current performance of hospital pharmacy specialists trained at a tertiary hospital in Spain","authors":"B. Santos Ramos, H. Rodríguez-Ramallo, A. Rodríguez-Pérez, L. Rodríguez Defrancisco, M. Fernández González","doi":"10.1136/ejhpharm-2023-eahp.465","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.465","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"257 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72952828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.454
G. Miron Elorriaga, Y. Viseda Torrellas, M. Palacios Filardo, M. Cardenas Sierra, FJ Goikolea Ugarte, A. Martin Torrente, L. Torio Alvarez, O. Ibarra Barrueta, P. Gemio Zumalave, M. Carmona Oyaga, A. Gomez De Segura Sarobe
{"title":"5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer","authors":"G. Miron Elorriaga, Y. Viseda Torrellas, M. Palacios Filardo, M. Cardenas Sierra, FJ Goikolea Ugarte, A. Martin Torrente, L. Torio Alvarez, O. Ibarra Barrueta, P. Gemio Zumalave, M. Carmona Oyaga, A. Gomez De Segura Sarobe","doi":"10.1136/ejhpharm-2023-eahp.454","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.454","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83829949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.379
M. Falcón Cubillo, L. Rodríguez-de Francisco, Á. Órpez-Ramírez, A. Rodríguez-Pérez, A. Villalba-Moreno, M. López-Feijoó, M. Fernández-González
{"title":"4CPS-033 Evaluation of the effectiveness of reinduction or intensification with ustekinumab in inflammatory bowel disease","authors":"M. Falcón Cubillo, L. Rodríguez-de Francisco, Á. Órpez-Ramírez, A. Rodríguez-Pérez, A. Villalba-Moreno, M. López-Feijoó, M. Fernández-González","doi":"10.1136/ejhpharm-2023-eahp.379","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.379","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82230301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01DOI: 10.1136/ejhpharm-2023-eahp.356
R. Claramunt García, M. Merino Almazán, T. Sánchez Casanueva, N. García Gomez
{"title":"1ISG-003 Protocol for the optimisation of pharmaceutical validation in hospitalised patients","authors":"R. Claramunt García, M. Merino Almazán, T. Sánchez Casanueva, N. García Gomez","doi":"10.1136/ejhpharm-2023-eahp.356","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.356","url":null,"abstract":"","PeriodicalId":19619,"journal":{"name":"Oral Presentations - Late-Breaking Proffered Abstracts","volume":"1995 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82444158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：